More on FTRE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-100.0% Growth)
- Ratings (3.3 Score)

Upcoming Events

- Earnings (8/11/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Fortrea (NQ:FTRE)
Delayed: 9.61 -0.31 (3.13%)
Prev. Close $9.92  
Open$9.63 
52 Wk High$ 
52 Wk Low$ 
Day High$9.98 
Day Low$9.42 
P/E N/A  
EPS$ 
Volume1,248,507 

Friends, Peers and Foes (?): FTRE.V, CYTK, WBTN, EU, LRN (more...)

Mar 5, 2026 04:37 PM Fortrea (FTRE) PT Lowered to $13 at Mizuho
Feb 27, 2026 07:06 AM Fortrea (FTRE) PT Lowered to $16 at Truist Securities
Feb 27, 2026 06:54 AM Fortrea (FTRE) PT Lowered to $16 at Baird
Feb 27, 2026 05:30 AM Fortrea (FTRE) PT Lowered to $12 at Barclays
Feb 26, 2026 04:08 PM Form 10-K Fortrea Holdings Inc. For: Dec 31
Feb 26, 2026 06:39 AM FTRE (FTRE) Misses Q3 EPS by 44c ; Offers Guidance
Feb 26, 2026 06:12 AM Form 8-K Fortrea Holdings Inc. For: Feb 26
Feb 26, 2026 06:00 AM Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance
Feb 17, 2026 05:07 PM Form SCHEDULE 13G/A Fortrea Holdings Inc. Filed by: Sessa Capital (Master), L.P.
Feb 17, 2026 07:00 AM Fortrea names Oren Cohen chief medical officer, Scott Dove clinical head
View All Articles

Entities mentioned with FTRE

View All Entities